Skip to navigation Skip to main content

Your search for apixaban returned 3 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Lea Eslava-Kim, PharmD remove
Post remove
Older than 2 years remove
News remove

Your search for apixaban returned 3 results

Sort Results:

Relevant Recent
Drugs in the Pipeline

Reversal Agent for Factor Xa Inhibitors Under FDA Review

Publish Date
Portola Pharmaceuticals announced the submission of a Biologics License Application (BLA) to the Food and Drug Administration (FDA) for its investigational agent andexanet alfa, as a universal reversal agent for patients anticoagulated with an oral or injectable Factor Xa inhibitor who experience a serious uncontrolled bleeding event or who require urgent or emergency surgery. There is currently no…
Drugs in the Pipeline

FDA to Review New Warfarin Formulation

Publish Date
Accu-Break Pharmaceuticals (ABP) announced that the Food & Drug Administration (FDA) has accepted for filling the New Drug Application (NDA) for Warfarin Potassium.
Drugs in the Pipeline

FDA Wants More Data for Anticoagulant Antidote AndexXa

Publish Date
The FDA has issued a Complete Response Letter (CRL) to the Biologics License Application (BLA) of AndexXa (andexanet alfa; Portola) as a reversal agent for life-threatening or uncontrolled bleeding due to Factor Xa inhibitors.